PF-Atlas › Clinical Trials › NCT02823964
EASY: Extended Access to Sollpura Over Years
Liprotamase · Phase 4
Registry ID
NCT02823964
Phase
Phase 4
Status
Completed
Drug / intervention
Liprotamase
Sponsor
Anthera Pharmaceuticals
Start
2016-09
Enrollment
25
Locations
15
About this trial
Liprotamase consists of 3 soluble, non-porcine digestive enzymes, lipase, protease, and amylase, combined in a fixed ratio. Liprotamase is stable in the stomach and can be formulated without enteric coating for administration either as a capsule or as a dosing solution dissolved in water or juice.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT02823964 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.